Clearing the Nuclear Haze: The Push Against Misinformation in the Philippines

In a bid to reshape the narrative surrounding nuclear energy in the Philippines, Senator Alan Peter Cayetano has highlighted the pervasive impact of misinformation on public opinion. Addressing this issue, he emphasized the importance of a comprehensive education campaign to illuminate the true potential of nuclear power.

During a Senate Committee on Science and Technology hearing on the Philippine National Nuclear Energy Safety Act, which Cayetano chairs, a clarion call was made to the Philippine Nuclear Research Institute (PNRI) to intensify public awareness efforts. Dr. Carlo Arcilla of DOST-PNRI was encouraged to broaden the discourse, shedding light on nuclear energy's vast applications beyond just power generation, including its benefits in medicine, industry, and agriculture.

Dr. Arcilla pinpointed 'fake news' as a significant barrier to nuclear energy adoption, noting the common misconception equating nuclear technology solely with weaponry. Cayetano echoed this sentiment, underscoring the challenge of transforming public perception to embrace the advantages of nuclear energy.

The legislative focus is on the proposed Philippine Nuclear Regulation Act, aiming to establish the Philippine Atomic Energy Regulatory Authority (PhilATOM). This independent entity would oversee the licensing of facilities using radioactive materials and promote the safe use of nuclear energy across various sectors.

Cayetano reassured the public that the initiative seeks to create a knowledgeable regulatory body to evaluate nuclear energy's viability and safety in the Philippines, rather than outright promotion or dismissal of the technology. He clarified that while PhilATOM would handle regulatory aspects, research functions would remain with DOST-PNRI.

The senator underscored the urgency of enacting PhilATOM to capitalize on nuclear energy's potential benefits swiftly, pledging to fast-track the bill's progress in the Senate. The proposed authority aims to amalgamate the regulatory capabilities of PNRI's Nuclear Regulatory Division and the FDA's Center for Device Regulation and Health, ensuring adherence to international standards.